Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2010
10/27/2010CN101870971A Method for real-time detecting HBV through PCR
10/27/2010CN101870968A Triphenylmethane dye decolorization enzyme and application thereof
10/27/2010CN101870966A Cellulose degrading enzyme with glucosidase/xylosidase dual functions and preparation method and application thereof
10/27/2010CN101870963A Recombinant Newcastle disease virus attenuated vaccine strain for expressing dog interferon (alpha, beta or gamma)
10/27/2010CN101870956A Cellulase-producing fungus agent and application thereof
10/27/2010CN101870735A Novel high-glycosylation erythropoietin immune fusion protein
10/27/2010CN101870734A Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof
10/27/2010CN101870733A Poultry IL-2 and newcastle disease virus HN gene recombination fusion protein and application thereof
10/27/2010CN101870729A Coagulation factor vii polypeptides
10/27/2010CN101870727A Protein related to rice grain shape and height and coding gene and application thereof
10/27/2010CN101869855A Nucleic acid separation and detection method and test tube suitable for method
10/27/2010CN101869715A Cell particles carrying interfering ribonucleic acid (RNA), preparation method and application thereof
10/27/2010CN101869705A Streptococcus iniae vaccine and preparation and application thereof
10/27/2010CN101869575A Modulation of WRN-mediated telomere-initiated cell signaling
10/27/2010CN101579527B HLA Specific human cytomegalovirus Multi-epitope adenovirus DNA Vaccine of Chinese population
10/27/2010CN101440366B Specific fragment tightly linked to musk melon powdery mildew resistance gene Pm-2F and obtaining method thereof
10/27/2010CN101434937B Paulownia 4-coumaric acid: coenzyme A ligase gene and use thereof
10/27/2010CN101402964B Alkali-fast high-activity alkalescent xylanase and encoding gene thereof
10/27/2010CN101392289B Kit and method for detecting pseudomonas aeruginosa by loop-mediated isothermal amplification method
10/27/2010CN101358194B Spirulina phycobiliprotein alpha subunit total protein gene and encoding protein thereof
10/27/2010CN101230330B Subtilisin-like protease gene recombination disinsection engineering bacteria and method for preparing inocula
10/27/2010CN101173290B Chemically synthesized HSV1 virus gB glucoprotein extracellular region gene fragment, representation and application of the same
10/27/2010CN101142315B Method for preparing dipeptide
10/27/2010CN101070542B Intensified tubercle-resisting action of human interleukin 24
10/27/2010CN101044162B GLP-1 analog fusion protein formulations
10/26/2010USRE41894 Hepatitis C inhibitor tri-peptides
10/26/2010USRE41888 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
10/26/2010US7821635 In-situ detection and analysis of methane in coal bed methane formations with spectrometers
10/26/2010US7820891 Maize variety PHV6K
10/26/2010US7820890 Inbred corn line G07-NPXA6496
10/26/2010US7820889 Inbred corn line LLD19BM
10/26/2010US7820888 Cotton variety MCS0701B2RF
10/26/2010US7820887 Cotton variety 05Q153
10/26/2010US7820886 Soybean variety RJS22001
10/26/2010US7820885 Soybean variety XB25U08
10/26/2010US7820883 transgenic plant having increased resistance to a picolinate auxin herbicide; has inhibited expression of the wild-type AFB5 gene
10/26/2010US7820882 Overexpression of a NAC coding sequence can accelerate senescence and increase grain protein content ; delaying senescence in a wheat plant by inhibiting expression of an endogenous WNAC gene in the plant
10/26/2010US7820881 Using vector transformation to generate and propagate plants with enhanced D-type Cyclin Dependent Kinase (CDKD) expression in seeds; enhancing cell division in plants
10/26/2010US7820880 targeted integration of nucleotide sequences into a transformed plant; transfer cassettes comprising nucleotide sequences of interest flanked by non-identical recombination sites are introduced into a plant comprising a target site; plants with disease resistance, insect resistance, nutritional value
10/26/2010US7820879 generating petunia transformants overexpressing the ZPT2-3 gene under the control of the CamV 35S promoter ; no adverse effects on plant growth
10/26/2010US7820878 Production of ungulates, preferably bovines that produce human immunoglobulins
10/26/2010US7820877 Human heavy chain variable regions, human kappa light chain variable regions and encodes only mu isotype; human kappa light chain variable regions and encodes mu and gamma-2 isotypes; double-inactivated mouse Ig locus
10/26/2010US7820876 Animal model for evaluating neurodegenerative disorders and identifying neuroprotective agents
10/26/2010US7820809 Short interfering RNA sequences for use in the treatment and prevention of diabetes, alzheimer's and cancer; gene expression inhibition
10/26/2010US7820808 Antisense agent which prevents DNA replication
10/26/2010US7820807 can bind to and stimulate professional and non-professional human antigen-presenting cells, enhance the stimulatory effect of CD40L on CD40 positive cells and/or induce phenotypical maturation of monocyte derived dendritic cells
10/26/2010US7820806 in high yields, with native conformation, and/or in soluble form include solubilizing in non-ionic or zwitterionic detergents; comprises polynucleotide encoding a multiple-membrane-spanning CD20 polypeptide
10/26/2010US7820795 Evolution of a protein x by random mutagenesis of the L. fermentum ntd gene, transforming E coli cells, culturing and selecting surviving cells; biosynthesis of transferase; anticarcinogenic agents; infectious diseases
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820786 Synthetic peptides and uses therefore
10/26/2010US7820722 Comprises a multi-carbon backbone having an at least partially neutralized carboxy or sulfonic functional group and also one or more side chains that have one or more carbon atoms and, optionally, one or more functional groups.
10/26/2010US7820635 Therapy for cancer; Alzheimer's disease; using Rna sequences; control degradation , block translation of messenger Rna ; transcription product of target gene encoding clusterin
10/26/2010US7820634 contacting cells in vivo with composition comprising collagenous matrix of submucosa tissue delaminated from both tunica muscularis and luminal portion of tunica mucosa of warm-blooded vertebrates, and added exogenous deoxyribonucleic acid
10/26/2010US7820633 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte
10/26/2010US7820632 For inhibiting expression of human immunodeficiency virus (HIV); for use in vitro/vivo
10/26/2010US7820624 which bind to human immature dendritic cells; non-viral transfection mixture comprising lipid component, polycationic nucleic acid-binding component, and peptide; gene expression inhibition; kits
10/26/2010US7820622 based human tetranectin C-type lectin like domains; rheumatoid arthritis, psoriasis or Crohn's disease; vectors, host cell, bioassay
10/26/2010US7820621 also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis
10/26/2010US7820453 Reacting astemizole with potassium channel moderators; complexing; calibration; kits
10/26/2010US7820447 drug screening; for carcinomas, especially lymphoma carcinomas
10/26/2010US7820443 Improving transfer of plasmids/nucleotide sequences into escherichia; mixing a plasmid DNA with the competent cells suspending within ionic solution to form a mixture, plating the mixture on a warm selective medium, and culturing the mixture on the medium
10/26/2010US7820442 expression of AID in Escherichia coli gives a mutator phenotype yielding DNA nucleotide transitions at dG/dC; mutation frequency is enhanced by deficiency in uracil-DNA glycosylase indicating that AID acts by deaminating dC residues in DNA
10/26/2010US7820441 Production of viral vectors
10/26/2010US7820440 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
10/26/2010US7820439 Using murine pluripotent stem cells to generate culture of gamma aminobutyric acid (GABA) expressing neurons for use in treatment and prevention of neurodegenerative disorders; cell replacement therapies; regenerative medicines
10/26/2010US7820436 Genetic engineered herpes virus genomes; vaccine; gene transfer into T lymphoid cells comprising infecting a T lymphoid cell with a recombinant herpesvirus
10/26/2010US7820435 Expression vector for use as gene transfer tools; gene therapy
10/26/2010US7820424 Modified hydrolase for use as template for inverse polymerase chain reaction
10/26/2010US7820423 Method and a system for predicting protein functional site, a method for improving protein function, and a function-modified protein
10/26/2010US7820421 Ketoreductases and uses thereof
10/26/2010US7820413 Incrementally truncated nucleic acids and methods of making same
10/26/2010US7820410 Proteins with high immunoreactivity and method for their production
10/26/2010US7820409 Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera
10/26/2010US7820408 isolated DNA methyltransferase; catalyzes the methylation of cytosine in the sequence GCNGC
10/26/2010US7820403 Acyltransferase -1 (ACTR-1); for identifying modulators or are useful themselves as compositions for diagnosis and treatment of disease or disorder that arise from malfunction of the regulation of triacylglycerol (triglyceride) and phospholipid biosynthesis e.g. atherosclerosis; cardiovascular disorders
10/26/2010US7820395 diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein; reducing HIV viral loads
10/26/2010US7820392 for detecting the presence of the transgene/genomic insertion region; for transgenic glyphosate tolerance; genetic engineering
10/26/2010US7820387 Detection and characterization of nucleic acid sequences and variations in nucleic acid sequences; a FEN-1 endonuclease is immobilized on a support and cleaves target nucleic acids in a site-specific manner
10/26/2010US7820384 Methods and compositions for protein expression and purification
10/26/2010US7820379 Process for high throughput screening of CpG-based immuno-agonist/antagonist
10/26/2010US7820378 Spectrometric analysis ; splitting compound; measurement signals; calibration
10/26/2010US7820376 obtaining a prognosis for a patient having or at risk of developing septic shock, systemic inflammatory response syndrome (SIRS); determining a protein C promoter genotype a polymorphism in the protein C promoter region of the patient, comparing the determined genotype with known genotypes
10/26/2010US7820375 Use of a protein of the CRMP family for treating diseases related to the immune system
10/26/2010US7820182 Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010US7820170 monoclonal antibody exhibit antagonist activity of the anti-CD40 antibody; antiproliferative agents; controlling cell differentiation; anticarcinogenic agents; Hodgkin's disease, leukemias
10/26/2010US7820169 inhibiting the activity of tumor necrosis factor TNF in a patient having rheumatoid arthritis or psoriatic arthritis, by administering a composition comprising an effective amount of human anti-TNF antibody comprising a heavy chain variable region comprising SEQ ID NO:7 and a light chain variable
10/26/2010US7820168 Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17
10/26/2010US7820160 Midkine inhibitory compositions for the treatment of angiostenosis
10/26/2010US7820157 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine
10/26/2010US7819796 Embryo modification and implantation
10/26/2010CA2579391C Anti-a33 antibody
10/26/2010CA2526893C Inhibition of the expression of huntingtin gene
10/26/2010CA2443840C Cripto blocking antibodies and uses thereof
10/26/2010CA2426398C Methods of modifying eukaryotic cells
10/26/2010CA2416602C Nucleotide sequences of a new class of diverged delta-9 stearoyl-acp desaturase genes
10/26/2010CA2416277C Increased separation efficiency via controlled aggregation of magnetic nanoparticles
10/26/2010CA2409698C Neural progenitor cell populations
10/26/2010CA2398707C C1 inhibitor produced in the milk of transgenic mammals
10/26/2010CA2393343C Nadh oxidase from lactobacillus
1 ... 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 ... 4023